Close Menu

NEW YORK – Ares Genetics, a Curetis Group company, will collaborate with BGI Group to make molecular tests for coronavirus 2019-nCoV available in Europe.

Ares will launch a next-generation sequencing testing service for the virus using BGI reagents. The firm will also collaborate, along with Curetis and BGI, in the distribution of NGS and PCR testing kits.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers are developing a breath test to determine how severe patients' methylmalonic acidemia disease is, FierceBiotech reports.

NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.

Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.